Matrixyl guide: palmitoyl pentapeptide-4, matrikine signaling, and the collagen evidence
A complete guide to matrixyl (palmitoyl pentapeptide-4, PAL-KTTKS) in skincare — the matrikine signaling mechanism (degraded collagen fragment mimicking that signals fibroblasts to synthesize new collagen), Lintner 2002 in vitro collagen upregulation and clinical evidence, matrixyl 3000 (the PAL-KTTKS + PAL-GHK combination), matrixyl synthe'6 (a different mechanism targeting collagen VI and laminin), why palmitate conjugation matters for penetration, concentration ranges, and how matrixyl fits alongside GHK-Cu and argireline in a complete peptide routine.
· By MedSpot Editorial · 4 min read
Matrixyl is the most widely studied signal peptide in anti-aging skincare — a fatty acid-conjugated pentapeptide that communicates to fibroblasts through the skin's natural collagen damage-sensing mechanism. Here is the complete evidence-based guide.
What matrixyl is
Signal peptide classification
Signal peptides are short amino acid sequences that mimic fragments of extracellular matrix proteins — they function as biological signals telling cells to produce specific proteins. They are distinct from:
- Carrier peptides (GHK-Cu — carry metal ions to enzyme active sites)
- Neurotransmitter-inhibiting peptides (argireline — interfere with muscle contraction signaling)
Matrixyl (palmitoyl pentapeptide-4, PAL-KTTKS) is a fatty acid-conjugated signal peptide consisting of:
- Palmitoyl group (PAL): A 16-carbon fatty acid chain that dramatically improves lipid solubility and stratum corneum penetration — peptides without the palmitate conjugate penetrate poorly through the lipid-rich barrier
- KTTKS pentapeptide: Lysine-Threonine-Threonine-Lysine-Serine — a sequence derived from the C-terminal pro-domain of procollagen type I
The matrikine mechanism
How collagen degradation signals new synthesis
The KTTKS sequence is not arbitrary — it is a matrikine: a bioactive fragment released when collagen is degraded by matrix metalloproteinases (MMPs) during normal tissue remodeling.
The signaling logic:
- MMPs cleave collagen in the extracellular matrix (ECM) → fragment KTTKS is released
- Dermal fibroblasts have cell surface receptors (specifically β1-integrin and CD44) that recognize KTTKS
- KTTKS binding activates intracellular signaling → fibroblasts upregulate procollagen I, III, and fibronectin synthesis
- New collagen is deposited to replace the degraded ECM
The matrixyl strategy: Apply the KTTKS sequence topically → fibroblasts detect it as a signal of collagen degradation → upregulate synthesis without actual collagen degradation needing to occur.
The palmitoyl conjugation solves the delivery problem: lipid-soluble PAL-KTTKS penetrates the stratum corneum and diffuses to the papillary dermis where fibroblasts reside.
Evidence
Lintner et al. 2002
Lintner K, Peschard O. (2000). Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. International Journal of Cosmetic Science, 22(3), 207–218.
In vitro: PAL-KTTKS at 1–10 nM concentrations significantly upregulated procollagen I and fibronectin synthesis in human fibroblast cultures — effective at extremely low concentrations, which explains why sub-1% concentrations in formulations can be meaningful.
Clinical component: 3 ppm PAL-KTTKS in an emulsion base applied twice daily for 12 weeks produced significant reduction in wrinkle area and depth on optical profilometry — compared to vehicle.
Key number: 3 ppm = 0.0003%. The fibroblast receptor response is highly sensitive — meaningful biological activity at very low concentrations, which is why position far down an ingredient list does not indicate inefficacy for this specific peptide.
Katayama et al. 1993
Katayama K, Armendariz-Borunda J, Raghow R, Kang AH, Seyer JM. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. Journal of Biological Chemistry, 268(14), 9941–9944.
The foundational study establishing that the KTTKS sequence from procollagen's C-propeptide activates collagen synthesis in fibroblasts — the upstream biochemistry validating the matrixyl mechanism before the cosmetic ingredient was developed.
Matrixyl variants
Original matrixyl: PAL-KTTKS (palmitoyl pentapeptide-4)
The original formulation — the basis for all Lintner clinical data.
Matrixyl 3000: PAL-KTTKS + PAL-GHK
Palmitoyl-GHK (PAL-GHK) is the copper-free version of the GHK sequence conjugated to palmitate. Matrixyl 3000 combines:
- PAL-KTTKS (matrikine signaling → procollagen I/III)
- PAL-GHK (different receptor; targets elastin, fibronectin, and collagen IV)
The combination targets broader ECM components than either peptide alone — collagen I/III/IV, fibronectin, elastin simultaneously. Many studies cited as "matrixyl" evidence used matrixyl 3000 rather than the original — verify which formulation is in the product.
Matrixyl synthe'6
A different signal peptide complex targeting six structural proteins of the basement membrane zone: collagen I, III, IV, and fibronectin, laminin, and hyaluronic acid. Not a matrikine mechanism — a different receptor signaling pathway. Used in products targeting deeper dermis remodeling.
Concentration: reading ingredient lists
PAL-KTTKS is effective at 3–5 ppm (parts per million) in published studies — meaning it can be listed well toward the bottom of an ingredient list and still be therapeutically relevant. Unlike some actives where position = dose, signal peptides are receptor-mediated at very low concentrations.
Look for:
- "Palmitoyl pentapeptide-4" or "palmitoyl pentapeptide-3" (older INCI name)
- "Matrixyl" is a trade name; INCI name is palmitoyl pentapeptide-4
- Combined with "palmitoyl tripeptide-1" (PAL-GHK) = matrixyl 3000
Matrixyl in a complete peptide routine
| Peptide | Type | Mechanism | Target |
|---|---|---|---|
| Matrixyl (PAL-KTTKS) | Signal | Matrikine → procollagen I/III | Collagen synthesis |
| GHK-Cu | Carrier | TGF-β + MMP inhibition | Collagen + tissue repair |
| Argireline | Neurotransmitter-inhibiting | SNARE partial block | Dynamic expression lines |
| PAL-GHK (matrixyl 3000) | Signal | Integrin → elastin/fibronectin/collagen IV | Broader ECM |
A serum combining these categories addresses collagen synthesis, matrix degradation inhibition, and expression line softening simultaneously — the rationale behind multi-peptide formulations.
Looking for an anti-aging skincare consultation? Browse med spa providers on MedSpot →